risk of thyroid cancer with semaglutide and Ozempic: There's a lot controversy surrounding this topic, so let's dive a little deeper Long-term cancer risk in users

Victoza (liraglutide) is a once-daily injection for type 2 diabetes that was once a market leader

Thats why, notes Kushner, when a person uses a GLP-1 agonist, they may feel less hungry, have less cravings and thoughts of food, and feel more full after a meal and between meals. They may also raise your resting metabolism

This tolerance is clinically irrelevant for GLP-1 medications, which have wide therapeutic windows

Heres how NutriKane D supports natural GLP-1 pathways: Unique Sugarcane Flour The base ingredient is a specialised sugarcane fibre, rich in bioactive compounds and resistant to digestion in the small intestine

Experts say the exact amount of risk isn't known, though it's very low